ASK REDCHAT ANYTHING ABOUT FENNEC PHARMACEUTICALS INC.
Fennec Pharmaceuticals Inc. (NASDAQ: FENC)
Listen to this Section
$8.71
-0.4550
(
-4.97% )
61.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| PEDMARK™ (sodium thiosulfate)DetailsHearing loss |
Approved |
Market Data
|
| Open |
$8.71 |
| Previous Close |
$9.16 |
| Volume |
61.4K |
| Market Cap |
$317.50M |
| Day Range |
$8.69 - $9.53 |
| 52 Week Range |
$5.65 - $10.45 |
| Shares Outstanding |
34.74M |
| Change % |
-4.97% |
| Net Change |
▼ -0.4550 |
| Insider Ownership |
-0.11% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Pharmaceuticals and Biotechnology |
| IPO Year | 2002 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-900,726.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2025-05-19 |
Buy |
1035.00 |
Hackman Jeffrey S. |
| 2024-08-01 |
Sale |
-1042.00 |
Andrade Robert |
| 2024-08-01 |
Sale |
-2431.00 |
Raykov Rosty |
| 2024-07-08 |
Sale |
-1792.00 |
RALLIS CHRIS A |
| 2024-07-02 |
Sale |
-1042.00 |
Andrade Robert |
| 2024-07-02 |
Sale |
-2431.00 |
Raykov Rosty |
| 2024-06-03 |
Sale |
-2431.00 |
Raykov Rosty |
| 2024-06-03 |
Sale |
-1042.00 |
Andrade Robert |
| 2024-05-21 |
Sale |
-200000.00 |
Raykov Rosty |
| 2024-05-21 |
Sale |
-50000.00 |
Haigh Adrian |